Medexus Pharmaceuticals Inc.

MDP.TOTSXHealthcare● Active

$3.95

+$0.04(+1.02%)

Market Cap$127586501

P/E Ratio—

52W High$4.17

52W Low$2.47

Avg Volume51K

Open$3.86

Beta1.84

Cash on Hand Financials Revenue

Medexus Pharmaceuticals Inc. (MDP.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MDP.TO · cash on hand · updated Mar 31, 2025

Core cash position

as of Mar 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$24.0M▲ +356.2% vs prior year

FY · as of Mar 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$24.0M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+356.2%

vs prior fiscal year

Latest Quarter

$15.0M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: March 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$24.0MCash on Hand

Total Debt$37.2MTotal Debt

Net Cash / Net Debt−$13.2MNet Debt Position

Cash vs Debt Ratio

Cash 39%Medexus Pharmaceuticals Inc. cash as % of market cap: 18.79%% · MCap $0BDebt 61%

Medexus Pharmaceuticals Inc. carries a net debt position of $13.2M. Total debt ($37.2M) exceeds cash on hand ($24.0M). Medexus Pharmaceuticals Inc. cash vs debt ratio: 39% cash / 61% debt.

Net Cash = Cash & ST Investments − Total Debt$24.0M − $37.2M = −$13.2M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

MDP.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

MDP.TO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Mar 31, 2025LatestFY$24.0M+356.2%

Mar 31, 2024FY$5.3M-59.8%

Mar 31, 2023FY$13.1M+30.5%

Mar 31, 2022FY$10.0M-46.4%

Mar 31, 2021FY$18.7M+257.3%

MDP.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

MDP.TO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Medexus Pharmaceuticals Inc.YOU

MDP.TO

$24.0M$128M18.8%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Medexus Pharmaceuticals Inc. (MDP.TO) cash on hand as of March 31, 2025 is $24.0M, comprising $24.0M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Medexus Pharmaceuticals Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Medexus Pharmaceuticals Inc. cash reserves or cash position.

Medexus Pharmaceuticals Inc. annual cash on hand history shows increased +356.2% in 2025: increased +356.2% in 2025. Medexus Pharmaceuticals Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Medexus Pharmaceuticals Inc. carries total debt of $37.2M against cash of $24.0M, resulting in a net debt position of -$13.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

MDP.TO cash on hand · 5 questions

As of March 31, 2025, Medexus Pharmaceuticals Inc. (MDP.TO) has $23,973,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $23,973,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $14,975,000. Data sourced from the annual 10-K filing via FMP.

MDP.TO cash on handMDP.TO cash reservesMDP.TO cash 2025how much cash does MDP.TO have

▸ Source: FMP /balance-sheet-statement · US GAAP · Medexus Pharmaceuticals Inc. · Medexus Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: March 31, 2025